Odyssey Therapeutics
3 employees
Biotech
Public · $700.0M
Company details
Team Size3
IndustryBiotech
Funding
Total raised
$700.0M
Last stage
Public
Investors
General Catalyst
Total raised
$700.0M
Last stage
Public
Investors
Gary D. Glick
Serial biotech entrepreneur and chemist; previously founded Lycera Corporation, co-founded IFM Therapeutics and Scorpion Therapeutics; former emeritus professor of chemistry at the University of Michigan.
LinkedInDavid Pompliano
Co-founder of Odyssey Therapeutics, serving as Chief Innovation Officer.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.